Lu AG06479 / Lundbeck - LARVOL DELTA

Safety and Tolerability of Lu AG06479 in Healthy Young Men (clinicaltrials.gov) - P1; N=46; Terminated; Sponsor: H. Lundbeck A/S; N=66 ➔ 46; Recruiting ➔ Terminated; The study was terminated for strategic reasons.

Clinical • Enrollment change • Trial termination

Safety and Tolerability of Lu AG06479 in Healthy Young Men (clinicaltrials.gov) - P1; N=66; Recruiting; Sponsor: H. Lundbeck A/S; Trial completion date: Apr 2021 ➔ Jan 2022; Trial primary completion date: Apr 2021 ➔ Jan 2022

Clinical • Trial completion date • Trial primary completion date

Safety and Tolerability of Lu AG06479 in Healthy Young Men (clinicaltrials.gov) - P1; N=66; Recruiting; Sponsor: H. Lundbeck A/S

Clinical • New P1 trial